Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §102 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCKLA, ANNA GRACE | 1 | 52.4% | +55.0% |
| JOHANSEN, PETER N. | 1 | 58.9% | +24.3% |
| CORNET, JEAN P | 1 | 42.1% | +47.5% |
| STEVENS, MARK V | 1 | 65.5% | +41.9% |
| VALENROD, YEVGENY | 1 | 72.6% | +25.1% |
| SCHMITT, MICHAEL J | 1 | 56.6% | +21.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18204025 | PROCESSES FOR PREPARING ARIMOCLOMOL CITRATE AND INTERMEDIATES THEREOF | STEVENS, MARK V | 15d overdue |
| 17059516 | HSP70 PROTEIN LEVELS IN PBMC SAMPLES AS BIOMARKER FOR DISEASE | JOHANSEN, PETER N. | 85d |
| 18267591 | ARIMOCLOMOL FOR THE TREATMENT OF NIEMANN PICK DISEASE, TYPE C, IN PATIENTS WITH ER TYPE MISSENSE MUTATIONS | CORNET, JEAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18204025 | PROCESSES FOR PREPARING ARIMOCLOMOL CITRATE AND INTERMEDIATES THEREOF | STEVENS, MARK V | 15d overdue |
| 18011349 | ARIMOCLOMOL FOR TREATING GAUCHER DISEASE | VALENROD, YEVGENY | 9d |
| 17560549 | USE OF ARIMOCLOMOL IN THE TREATMENT OF NIEMANN PICK DISEASE | SCHMITT, MICHAEL J | 14d |
| 17059516 | HSP70 PROTEIN LEVELS IN PBMC SAMPLES AS BIOMARKER FOR DISEASE | JOHANSEN, PETER N. | 85d |
| 18695862 | DIOXAZINES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES | KUCKLA, ANNA GRACE | — |
| 18267591 | ARIMOCLOMOL FOR THE TREATMENT OF NIEMANN PICK DISEASE, TYPE C, IN PATIENTS WITH ER TYPE MISSENSE MUTATIONS | CORNET, JEAN P | — |
| Art Unit | Apps |
|---|---|
| 1628 | 2 |
| 1626 | 1 |
| 1644 | 1 |
| 1613 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18695862 | DIOXAZINES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES | KUCKLA, ANNA GRACE | 1626 | §102 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 17059516 | HSP70 PROTEIN LEVELS IN PBMC SAMPLES AS BIOMARKER FOR DISEASE | JOHANSEN, PETER N. | 1644 | §101§112 | Non-Final OA | 85d | Pending | Aug 01, 2023 |
| 18267591 | ARIMOCLOMOL FOR THE TREATMENT OF NIEMANN PICK DISEASE, TYPE C, IN PATIENTS WITH ER TYPE MISSENSE MUTATIONS | CORNET, JEAN P | 1628 | §102§103 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18204025 | PROCESSES FOR PREPARING ARIMOCLOMOL CITRATE AND INTERMEDIATES THEREOF | STEVENS, MARK V | 1613 | §103§112Other | Final Rejection | 15d overdue | Pending | May 31, 2023 |
| 18011349 | ARIMOCLOMOL FOR TREATING GAUCHER DISEASE | VALENROD, YEVGENY | 1628 | §103 | Final Rejection | 9d | Pending | Dec 19, 2022 |
| 17560549 | USE OF ARIMOCLOMOL IN THE TREATMENT OF NIEMANN PICK DISEASE | SCHMITT, MICHAEL J | 1629 | §103DP | Non-Final OA | 14d | Pending | Dec 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial